Capri Global Capital Limited has approved a proposal to raise up to ₹4,000 crore through the issuance of equity shares, debt securities, convertible securities, or warrants. This decision was taken at a board meeting held on October 14, 2026.

The company intends to utilize one or more permissible modes for this fundraising effort. These include rights issues, preferential issues on a private placement basis, public issues, qualified institutions placements, Foreign Currency Convertible Bonds (FCCBs), and External Commercial Borrowings (ECBs). The specific method and terms will be finalized in due course.

Regulatory Compliance and Timeline

The board's approval is subject to necessary regulatory and statutory approvals, including consent from shareholders. The company will disclose additional details regarding the securities issuance once the terms and conditions are finalized. This disclosure aligns with Regulation 30 and 51 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meeting commenced at 6:30 pm and concluded at 7:15 pm. The intimation regarding this outcome has been filed with BSE Limited, National Stock Exchange of India Limited, India International Exchange (IFSC) Limited, and NSE IFSC Limited.

Fundraising Structure Details

The following table outlines the key parameters of the proposed fundraising as disclosed by the company:

What the Numbers Show

The authorization for a ₹4,000 crore raise represents a significant capital expansion opportunity for Capri Global Capital. By keeping the instrument type flexible—ranging from equity to debt—the company retains strategic optionality to optimize its cost of capital based on market conditions at the time of execution. The broad range of permissible modes suggests the management is preparing for multiple market windows or investor segments.

Capri Global Capital Limited allotted 16,000 Series 18 Non-Convertible Debentures (NCDs) aggregating ₹160 crore on October 13, 2026. The subordinated, unsecured instruments were issued via private placement at a fixed coupon rate of 9.75% per annum.

The allotment was approved by the Management Committee following successful bidding on the BSE Bond-Electronic Bidding Platform. These NCDs have a face value of ₹1,00,000 each and are proposed to be listed on BSE Limited. The issuance forms part of the company's broader debt capital raising activities, which were previously flagged for consideration in an upcoming board meeting scheduled for October 14, 2026.

Instrument Details and Terms

The Series 18 NCDs are rated, listed, subordinated, taxable, redeemable, and transferable. They carry a tenure of 10 years from the date of allotment, with maturity scheduled for October 13, 2036. Interest is payable monthly and upon redemption. In the event of a payment default exceeding three months, the issuer is liable to pay additional interest at 2% per annum over the standard rate.

Broader Fundraising Context

This specific allotment aligns with the company's earlier disclosure regarding plans to raise funds through various instruments, including equity shares, debt securities, warrants, and other financial products. The broader fundraising strategy includes modes such as rights issues, preferential issues, public issues, qualified institutions placements, Foreign Currency Convertible Bonds (FCCBs), and External Commercial Borrowings (ECBs). These actions remain subject to regulatory approvals and shareholder consent.

The initial intimation regarding these fundraising possibilities was filed pursuant to Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company informed BSE Limited, National Stock Exchange of India Limited, India International Exchange (IFSC) Limited, and NSE IFSC Limited about the scheduled board meeting to consider these proposals.

Regulatory Compliance

The current allotment was disclosed under Regulation 30 and 51 of the SEBI (LODR) Regulations, 2015, read with Schedule III thereto. It also complies with the SEBI (Issue and Listing of Non-Convertible Securities) (Amendment) Regulations, 2026. The General Information Document dated March 30, 2026, and the Key Information Document dated October 8, 2026, governed the issuance process.

Previously, the trading window had been closed since October 1, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, due to the consideration of financial results for the quarter and half year ended September 30, 2026. Consequently, no separate trading window closure was required for this specific item.